Thomas E. Timbie - 31 Dec 2022 Form 5 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Reporting relationship: Director
Issuer ticker: TMCI
Reported as of: 31 Dec 2022
Net transaction value: $0
SEC form: 5
Accepted by SEC: 14 Feb 2023, 20:00:28 UTC
Prior SEC filing: 16 Dec 2022
Next SEC filing: 20 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Lisa Taylor as Attorney-in-fact for Thomas Timbie

Key filing fact

Thomas E. Timbie filed Form 5 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 14 Feb 2023.

Key facts

This page summarizes Thomas E. Timbie's Form 5 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Feb 2023, 20:00.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

TMCI transaction

Gift

Transaction value: $0
Shares: -15,000
Change %: -3.9%
Price: $0.000000
Shares after: 370,000
Date: 11 Nov 2022
Ownership: Pamela Timbie and Thomas Timbie as Trustees of the PAMELA F TIMBIE REV TRUST

TMCI holding

No transaction description listed

TMCI holding

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,299,069
Date: 31 Dec 2022
Ownership: Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Includes 2,295 RSUs.